Cytokine-secreting tumor cell vaccines

被引：104

作者：

Mach, N ^{[1
]}

Dranoff, G ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA

来源：

CURRENT OPINION IN IMMUNOLOGY | 2000年 / 12卷 / 05期

关键词：

D O I：

10.1016/S0952-7915(00)00144-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Modification of the tumor microenvironment with gene transfer techniques stimulates two immune mechanisms that effectuate tumor destruction. One involves improved tumor-antigen presentation for the development of specific cellular and humoral immunity. The second involves compromise of the tumor vasculature by soluble factors and leukocytes.

引用

页码：571 / 575

页数：5

共 59 条

[31]

Mackey MF, 1997, CANCER RES, V57, P2569

[32] INVITRO ACTIONS ON HEMATOPOIETIC-CELLS OF RECOMBINANT MURINE GM-CSF PURIFIED AFTER PRODUCTION IN ESCHERICHIA-COLI - COMPARISON WITH PURIFIED NATIVE GM-CSF [J].

METCALF, D ;

BURGESS, AW ;

JOHNSON, GR ;

NICOLA, NA ;

NICE, EC ;

DELAMARTER, J ;

THATCHER, DR ;

MERMOD, JJ .

JOURNAL OF CELLULAR PHYSIOLOGY, 1986, 128 (03) :421-431

[33] Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status:: a clinical phase I study [J].

Möller, P ;

Sun, Y ;

Dorbic, T ;

Alijagic, S ;

Makki, A ;

Jurgovsky, K ;

Schroff, M ;

Henz, BM ;

Wittig, B ;

Schadendorf, D .

BRITISH JOURNAL OF CANCER, 1998, 77 (11) :1907-1916

[34]

MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.iy.07.040189.001045

[35]

Naito Y, 1998, CANCER RES, V58, P3491

[36] Phase I trial of interferon-γ (IFN-γ) retroviral vector administered intratumorally to patients with metastatic melanoma [J].

Nemunaitis, J ;

Fong, T ;

Robbins, JM ;

Edelman, G ;

Edwards, W ;

Paulson, RS ;

Bruce, J ;

Ognoskie, N ;

Wynne, D ;

Pike, M ;

Kowal, K ;

Merritt, J ;

Ando, D .

CANCER GENE THERAPY, 1999, 6 (04) :322-330

[37] Effect of interleukin 12 on tumor induction by 3-methylcholanthrene [J].

Noguchi, Y ;

Jungbluth, A ;

Richards, EC ;

Old, LJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) :11798-11801

[38] New paths in human cancer serology [J].

Old, LJ ;

Chen, YT .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (08) :1163-1167

[39] Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1β converting enzyme cDNA [J].

Oshikawa, K ;

Shi, FS ;

Rakhmilevich, AL ;

Sondel, PM ;

Mahvi, DM ;

Yang, NS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (23) :13351-13356

[40] Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma [J].

Palmer, K ;

Moore, J ;

Everard, M ;

Harris, JD ;

Rodgers, S ;

Rees, RC ;

Murray, AK ;

Mascari, R ;

Kirkwood, J ;

Riches, PG ;

Fisher, C ;

Thomas, JM ;

Harries, M ;

Johnston, SRD ;

Collins, MKL ;

Gore, ME .

HUMAN GENE THERAPY, 1999, 10 (08) :1261-1268

← 1 2 3 4 5 6 →